ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE)

Ng, Siew C.*; Kamm, Michael A.; Yeoh, Yun Kit; Chan, Paul K. S.; Zuo, Tao; Tang, Whitney; Sood, Ajit; Andoh, Akira; Ohmiya, Naoki; Zhou, Yongjian; Ooi, Choon Jin; Mahachai, Varocha; Wu, Chun-Ying; Zhang, Faming; Sugano, Kentaro; Chan, Francis K. L.中国医科大学; 1
Gut2020-1DOI: 10.1136/gutjnl-2019-319407
78被引6阅读
引用收藏
分享

摘要

Objective The underlying microbial basis, predictors of therapeutic outcome and active constituent(s) of faecal microbiota transplantation (FMT) mediating benefit remain unknown. An international panel of experts presented key elements that will shape forthcoming FMT research and practice. @@@ Design Systematic search was performed, FMT literature was critically appraised and a 1-day round-table discussion was conducted to derive expert consensus on key issues in FMT research. @@@ Results 16 experts convened and discussed five questions regarding (1) the role of donor and recipient microbial (bacteria, viruses, fungi) parameters in FMT; (2) methods to assess microbiota alterations; (3) concept of keystone species and microbial predictors of FMT, (4) influence of recipient profile and antibiotics pretreatment on FMT engraftment and maintenance and (5) new developments in FMT formulations and delivery. The panel considered that variable outcomes of FMT relate to compositional and functional differences in recipient's microbiota, and likely donor-associated and recipient-associated physiological and genetic factors. Taxonomic composition of donor intestinal microbiota may influence the efficacy of FMT in recurrent Clostridioides difficile infections and UC. FMT not only alters bacteria composition but also establishes trans-kingdom equilibrium between gut fungi, viruses and bacteria to promote the recovery of microbial homeostasis. FMT is not a one size fits all and studies are required to identify microbial components that have specific effects in patients with different diseases. @@@ Conclusion FMT requires optimisation before their therapeutic promise can be evaluated for different diseases. This summary will guide future directions and priorities in advancement of the science and practice of FMT.

学科与关键词

关键词
CLOSTRIDIUM-DIFFICILE INFECTIONBLIND RANDOMIZED-TRIALACTIVE ULCERATIVE-COLITISINTESTINAL MICROBIOTAINSULIN SENSITIVITYCLINICAL REMISSIONMOUSE MODELDONOR FUNGIEFFICACYENGRAFTMENT
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Gut
发表日期
2020-01
卷期
第 69 卷, 第 1 期
页码
83-91
DOI
10.1136/gutjnl-2019-319407
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
1区
成果收录
SCIE
资助标注
Center for Gut Microbiota Research, Faculty of Medicine, The Chinese University of Hong Kong

作者

  • N

    Ng, Siew C. (通讯) (第一作者)

    chinese univ hong kong

  • K

    Kamm, Michael A.

查看全部 16 位作者收起作者
  • Y

    Yeoh, Yun Kit

    chinese univ hong kong

  • C

    Chan, Paul K. S.

    chinese univ hong kong

  • Z

    Zuo, Tao

    chinese univ hong kong

  • T

    Tang, Whitney

    chinese univ hong kong

  • S

    Sood, Ajit

  • A

    Andoh, Akira

  • O

    Ohmiya, Naoki

  • Z

    Zhou, Yongjian

    1

  • O

    Ooi, Choon Jin

  • M

    Mahachai, Varocha

  • W

    Wu, Chun-Ying

    china med univ

  • Z

    Zhang, Faming

    2 · nanjing med univ

  • S

    Sugano, Kentaro

  • C

    Chan, Francis K. L.

    chinese univ hong kong

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417